Report - CENTER FOR DRUG EVALUATION AND RESEARCH · SUBJECT: Final CMC Recommendation for NDA 202100, (Quillivant™) Methylphenidate HCl Extended-Release Oral Suspension (25 mg/5 mL), CMC

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form